FRANKLIN LAKES, N.J., Nov. 23, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, November 29, 2016, at 9:30 a.m. ET.
A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Tuesday, December 6, 2016.
About BD BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Contact: Kristen Cardillo, Communications – 201-847-5657 Monique N. Dolecki, Investor Relations – 201-847-5378
Advertisement
A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Tuesday, December 6, 2016.
Advertisement
About BD BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Contact: Kristen Cardillo, Communications – 201-847-5657 Monique N. Dolecki, Investor Relations – 201-847-5378
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-to-present-at-the-28th-annual-piper-jaffray-healthcare-conference-300367753.html
SOURCE BD (Becton, Dickinson and Company)
